毒物动力学信息学。

IF 2.2 4区 医学 Q3 PHARMACOLOGY & PHARMACY
Gilberto Padilla Mercado, Christopher Cook, Norman Adkins, Lucas Albrecht, Grace Cary, Brenda Edwards, Derik E Haggard, Nancy M Hanley, Michael F Hughes, Anna Jarnagin, Tirumala D Kodavanti, Evgenia Korol-Bexell, Anna Kreutz, Mayla Ngo, Caitlyn Patullo, Evelyn G Rowan, L McKenna Huse, Veronica A Correa, Branislav Kesic, Will Casey, Jennat Aboabdo, Kaitlyn Wolf, Risa Sayre, Bhaskar Sharma, Jonathan T Wall, Hiroshi Yamazaki, John F Wambaugh, Caroline L Ring
{"title":"毒物动力学信息学。","authors":"Gilberto Padilla Mercado, Christopher Cook, Norman Adkins, Lucas Albrecht, Grace Cary, Brenda Edwards, Derik E Haggard, Nancy M Hanley, Michael F Hughes, Anna Jarnagin, Tirumala D Kodavanti, Evgenia Korol-Bexell, Anna Kreutz, Mayla Ngo, Caitlyn Patullo, Evelyn G Rowan, L McKenna Huse, Veronica A Correa, Branislav Kesic, Will Casey, Jennat Aboabdo, Kaitlyn Wolf, Risa Sayre, Bhaskar Sharma, Jonathan T Wall, Hiroshi Yamazaki, John F Wambaugh, Caroline L Ring","doi":"10.1007/s10928-025-09977-4","DOIUrl":null,"url":null,"abstract":"<p><p>Toxicokinetic and pharmacokinetic (PK) summary parameters, such as C<sub>max</sub> (peak concentration), AUC (time-integrated area under the plasma concentration curve), and t<sub>1/2</sub> (elimination half-life from the body), are important information for understanding chemical safety in both pharmaceuticals and commercial industry. Although standardized tools exist for PK analysis of individual chemicals, new workflows can enhance chemoinformatic trend analysis. The Concentration versus Time Database (CvTdb) is a public repository of PK data at the U.S. Environmental Protection Agency (EPA). The CvTdb contains manually curated, standardized toxicokinetic data from hundreds of publications. Experimental time-course data of chemical concentrations in body fluids and tissues are extracted along with descriptive metadata. The advantage of standardized data is that it can be analyzed systematically. For example, we observe that 88.6% of replicate measurements of blood or plasma concentrations of chemicals after intravenous or oral dosing are within two-fold of the mean concentration. Although most experimental data have final timepoints within three days, some experiments extend up to a year, usually for long-lived chemicals. Here we have estimated PK parameters of CvTdb data using a custom R package, invivoPKfit. Standardized 1- and 2- compartmental PK model parameters were estimated using all data associated with a particular compound, including data that spans multiple references. We used invivoPKfit to estimate PK parameters such as volume of distribution (V<sub>d</sub>) and t<sub>1/2</sub>. The parameter values estimated with invivoPKfit are distributed similar to estimates made in the literature by a variety of methods. Overall, CvTdb serves as a standardized set of open data and for calibrating and evaluating PK models, while invivoPKfit allows for batch processing of this data type in a transparent and scalable manner. In addition to scientific insights, chemical risk assessment may be better informed by transparent, reproducible, and open-source workflows for PK informatics.</p>","PeriodicalId":16851,"journal":{"name":"Journal of Pharmacokinetics and Pharmacodynamics","volume":"52 3","pages":"30"},"PeriodicalIF":2.2000,"publicationDate":"2025-05-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Informatics for toxicokinetics.\",\"authors\":\"Gilberto Padilla Mercado, Christopher Cook, Norman Adkins, Lucas Albrecht, Grace Cary, Brenda Edwards, Derik E Haggard, Nancy M Hanley, Michael F Hughes, Anna Jarnagin, Tirumala D Kodavanti, Evgenia Korol-Bexell, Anna Kreutz, Mayla Ngo, Caitlyn Patullo, Evelyn G Rowan, L McKenna Huse, Veronica A Correa, Branislav Kesic, Will Casey, Jennat Aboabdo, Kaitlyn Wolf, Risa Sayre, Bhaskar Sharma, Jonathan T Wall, Hiroshi Yamazaki, John F Wambaugh, Caroline L Ring\",\"doi\":\"10.1007/s10928-025-09977-4\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Toxicokinetic and pharmacokinetic (PK) summary parameters, such as C<sub>max</sub> (peak concentration), AUC (time-integrated area under the plasma concentration curve), and t<sub>1/2</sub> (elimination half-life from the body), are important information for understanding chemical safety in both pharmaceuticals and commercial industry. Although standardized tools exist for PK analysis of individual chemicals, new workflows can enhance chemoinformatic trend analysis. The Concentration versus Time Database (CvTdb) is a public repository of PK data at the U.S. Environmental Protection Agency (EPA). The CvTdb contains manually curated, standardized toxicokinetic data from hundreds of publications. Experimental time-course data of chemical concentrations in body fluids and tissues are extracted along with descriptive metadata. The advantage of standardized data is that it can be analyzed systematically. For example, we observe that 88.6% of replicate measurements of blood or plasma concentrations of chemicals after intravenous or oral dosing are within two-fold of the mean concentration. Although most experimental data have final timepoints within three days, some experiments extend up to a year, usually for long-lived chemicals. Here we have estimated PK parameters of CvTdb data using a custom R package, invivoPKfit. Standardized 1- and 2- compartmental PK model parameters were estimated using all data associated with a particular compound, including data that spans multiple references. We used invivoPKfit to estimate PK parameters such as volume of distribution (V<sub>d</sub>) and t<sub>1/2</sub>. The parameter values estimated with invivoPKfit are distributed similar to estimates made in the literature by a variety of methods. Overall, CvTdb serves as a standardized set of open data and for calibrating and evaluating PK models, while invivoPKfit allows for batch processing of this data type in a transparent and scalable manner. In addition to scientific insights, chemical risk assessment may be better informed by transparent, reproducible, and open-source workflows for PK informatics.</p>\",\"PeriodicalId\":16851,\"journal\":{\"name\":\"Journal of Pharmacokinetics and Pharmacodynamics\",\"volume\":\"52 3\",\"pages\":\"30\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-05-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Pharmacokinetics and Pharmacodynamics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1007/s10928-025-09977-4\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Pharmacokinetics and Pharmacodynamics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10928-025-09977-4","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

毒代动力学和药代动力学(PK)总结参数,如Cmax(峰值浓度)、AUC(血浆浓度曲线下的时间积分面积)和t1/2(从体内消除半衰期),是了解药品和商业工业中化学品安全性的重要信息。虽然存在标准化的工具来分析单个化学品的PK,但新的工作流程可以增强化学信息学趋势分析。浓度与时间数据库(CvTdb)是美国环境保护署(EPA)的一个公共PK数据存储库。CvTdb包含来自数百种出版物的手动整理的标准化毒性动力学数据。提取体液和组织中化学物质浓度的实验时程数据以及描述性元数据。标准化数据的优点是可以进行系统的分析。例如,我们观察到88.6%的静脉或口服给药后血液或血浆化学物质浓度的重复测量值在平均浓度的两倍之内。虽然大多数实验数据的最终时间点在三天内,但有些实验通常会延长到一年,通常是针对寿命较长的化学品。在这里,我们使用自定义R包invivoPKfit估计了CvTdb数据的PK参数。标准化的1室和2室PK模型参数使用与特定化合物相关的所有数据进行估计,包括跨越多个参考的数据。我们使用invivoPKfit来估计PK参数,如分布体积(Vd)和t1/2。invivoPKfit估计的参数值分布与文献中各种方法估计的值相似。总的来说,CvTdb作为一组标准化的开放数据,用于校准和评估PK模型,而invivoPKfit允许以透明和可扩展的方式批量处理这种数据类型。除了科学见解之外,透明的、可重复的、开源的PK信息学工作流程可以更好地为化学品风险评估提供信息。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Informatics for toxicokinetics.

Toxicokinetic and pharmacokinetic (PK) summary parameters, such as Cmax (peak concentration), AUC (time-integrated area under the plasma concentration curve), and t1/2 (elimination half-life from the body), are important information for understanding chemical safety in both pharmaceuticals and commercial industry. Although standardized tools exist for PK analysis of individual chemicals, new workflows can enhance chemoinformatic trend analysis. The Concentration versus Time Database (CvTdb) is a public repository of PK data at the U.S. Environmental Protection Agency (EPA). The CvTdb contains manually curated, standardized toxicokinetic data from hundreds of publications. Experimental time-course data of chemical concentrations in body fluids and tissues are extracted along with descriptive metadata. The advantage of standardized data is that it can be analyzed systematically. For example, we observe that 88.6% of replicate measurements of blood or plasma concentrations of chemicals after intravenous or oral dosing are within two-fold of the mean concentration. Although most experimental data have final timepoints within three days, some experiments extend up to a year, usually for long-lived chemicals. Here we have estimated PK parameters of CvTdb data using a custom R package, invivoPKfit. Standardized 1- and 2- compartmental PK model parameters were estimated using all data associated with a particular compound, including data that spans multiple references. We used invivoPKfit to estimate PK parameters such as volume of distribution (Vd) and t1/2. The parameter values estimated with invivoPKfit are distributed similar to estimates made in the literature by a variety of methods. Overall, CvTdb serves as a standardized set of open data and for calibrating and evaluating PK models, while invivoPKfit allows for batch processing of this data type in a transparent and scalable manner. In addition to scientific insights, chemical risk assessment may be better informed by transparent, reproducible, and open-source workflows for PK informatics.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.90
自引率
4.00%
发文量
39
审稿时长
6-12 weeks
期刊介绍: Broadly speaking, the Journal of Pharmacokinetics and Pharmacodynamics covers the area of pharmacometrics. The journal is devoted to illustrating the importance of pharmacokinetics, pharmacodynamics, and pharmacometrics in drug development, clinical care, and the understanding of drug action. The journal publishes on a variety of topics related to pharmacometrics, including, but not limited to, clinical, experimental, and theoretical papers examining the kinetics of drug disposition and effects of drug action in humans, animals, in vitro, or in silico; modeling and simulation methodology, including optimal design; precision medicine; systems pharmacology; and mathematical pharmacology (including computational biology, bioengineering, and biophysics related to pharmacology, pharmacokinetics, orpharmacodynamics). Clinical papers that include population pharmacokinetic-pharmacodynamic relationships are welcome. The journal actively invites and promotes up-and-coming areas of pharmacometric research, such as real-world evidence, quality of life analyses, and artificial intelligence. The Journal of Pharmacokinetics and Pharmacodynamics is an official journal of the International Society of Pharmacometrics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信